Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis

Life-long anticoagulation is the recommended management for chronic thromboembolic pulmonary hypertension (CTEPH). Evidence regarding the use of direct oral anticoagulants (DOAC) for CTEPH is yet to be established. We performed a systematic review and meta-analysis to clarify the outcomes of CTEPH in patients who used DOAC or vitamin K antagonists (VKA).

Source: Thrombosis Research - October 9, 2023 Category: Hematology Authors: Yoshiko Ishisaka, Atsuyuki Watanabe, Hisato Takagi, David Steiger, Toshiki Kuno Source Type: research